JP2003517006A5 - - Google Patents

Download PDF

Info

Publication number
JP2003517006A5
JP2003517006A5 JP2001544774A JP2001544774A JP2003517006A5 JP 2003517006 A5 JP2003517006 A5 JP 2003517006A5 JP 2001544774 A JP2001544774 A JP 2001544774A JP 2001544774 A JP2001544774 A JP 2001544774A JP 2003517006 A5 JP2003517006 A5 JP 2003517006A5
Authority
JP
Japan
Prior art keywords
helix
concentration
syncytium
syncytium formation
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001544774A
Other languages
English (en)
Japanese (ja)
Other versions
JP4925540B2 (ja
JP2003517006A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/034194 external-priority patent/WO2001044286A2/en
Publication of JP2003517006A publication Critical patent/JP2003517006A/ja
Publication of JP2003517006A5 publication Critical patent/JP2003517006A5/ja
Application granted granted Critical
Publication of JP4925540B2 publication Critical patent/JP4925540B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001544774A 1999-12-16 2000-12-15 5−ヘリックスタンパク質 Expired - Fee Related JP4925540B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17104299P 1999-12-16 1999-12-16
US60/171,042 1999-12-16
US23457200P 2000-09-22 2000-09-22
US60/234,572 2000-09-22
PCT/US2000/034194 WO2001044286A2 (en) 1999-12-16 2000-12-15 Five-helix protein

Publications (3)

Publication Number Publication Date
JP2003517006A JP2003517006A (ja) 2003-05-20
JP2003517006A5 true JP2003517006A5 (https=) 2008-10-02
JP4925540B2 JP4925540B2 (ja) 2012-04-25

Family

ID=26866680

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001544774A Expired - Fee Related JP4925540B2 (ja) 1999-12-16 2000-12-15 5−ヘリックスタンパク質

Country Status (8)

Country Link
US (3) US7053179B2 (https=)
EP (1) EP1237912B1 (https=)
JP (1) JP4925540B2 (https=)
AT (1) ATE380822T1 (https=)
CA (1) CA2395291C (https=)
DE (1) DE60037450T2 (https=)
ES (1) ES2296665T3 (https=)
WO (1) WO2001044286A2 (https=)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150088A (en) 1997-04-17 2000-11-21 Whitehead Institute For Biomedical Research Core structure of gp41 from the HIV envelope glycoprotein
US6841657B2 (en) 1997-04-17 2005-01-11 Whitehead Institute For Biomedical Research Inhibitors of HIV membrane fusion
US6818740B1 (en) 1997-04-17 2004-11-16 Whitehead Institute For Biomedical Research Inhibitors of HIV membrane fusion
US7960504B2 (en) 1998-07-30 2011-06-14 Whitehead Institute For Biomedical Research Inhibitors of HIV membrane fusion
US6747126B1 (en) 1998-07-30 2004-06-08 Whitehead Institute For Biomedical Research Peptide inhibitors of HIV entry
CA2359892A1 (en) * 1999-01-08 2000-07-13 Panacos Pharmaceuticals, Inc. Methods of eliciting broadly neutralizing antibodies targeting hiv-1 gp41
CA2395291C (en) * 1999-12-16 2012-09-11 Whitehead Institute For Biomedical Research Five-helix protein
US20030082525A1 (en) * 1999-12-16 2003-05-01 Whitehead Institute For Biomedical Research Five-Helix protein
FR2819256B1 (fr) * 2001-01-05 2004-04-30 Aventis Pasteur Polypeptide induisant des anticorps neutralisant le vih
US6861253B2 (en) 2001-01-05 2005-03-01 Aventis Pasteur S.A. Polypeptide inducing antibodies neutralizing HIV
ATE295370T1 (de) 2001-05-31 2005-05-15 Conjuchem Inc Langwirkende fusionspeptid-inhibitoren für hiv- infektion
KR100614714B1 (ko) 2001-06-15 2006-08-21 에프. 호프만-라 로슈 아게 gp41 단편의 아세틸화
WO2003006056A2 (en) * 2001-07-11 2003-01-23 Genfa Zhou End-locked five-helix protein
EP1438333A4 (en) * 2001-09-27 2005-10-19 Tibotec Pharm Ltd ANTI-FUSION TEST
WO2003042388A1 (fr) * 2001-10-05 2003-05-22 Aventis Pasteur ANTIGENE POLYPEPTIDIQUE FORMANT UNE STRUCTURE MIMANT L'ETAT INTERMEDIAIRE DE gp41
US20030219451A1 (en) * 2001-10-29 2003-11-27 Whitehead Institute For Biomedical Research Stable helical C peptides and uses therefor
FR2832715A1 (fr) * 2001-11-29 2003-05-30 Hippocampe Polypeptides inhibiteurs de l'infectivite des virus de l'immunodeficience humaine
US20060241027A1 (en) * 2002-02-07 2006-10-26 Hans-Peter Hauser Hiv inhibiting proteins
US7056519B2 (en) 2002-05-17 2006-06-06 Aventis Pasteur S.A. Methods for inducing HIV-neutralizing antibodies
US20040076637A1 (en) * 2002-09-27 2004-04-22 Delmedico Mary Kay HIV-derived HR1 peptides modified to form stable trimers, and their use in therapy to inhibit transmission of human immunodeficiency virus
CA2443365C (en) * 2002-11-19 2010-01-12 F. Hoffmann-La Roche Ag Methods for the recombinant production of antifusogenic peptides
AU2003265420A1 (en) * 2003-08-14 2005-03-10 The Government Of The United States Of America, As Represented By The Department Of Health And Human Services Polypeptide multimers having antiviral activity
EP1747233A4 (en) * 2004-05-06 2007-04-25 COMPOUNDS FOR SPECIFIC VIRAL TARGET
JP5069558B2 (ja) * 2004-06-01 2012-11-07 メルク・シャープ・エンド・ドーム・コーポレイション HIVgp41融合中間物質の安定したペプチド模倣薬
EP1765398B1 (en) 2004-06-01 2011-07-13 Merck Sharp & Dohme Corp. Human antibodies interacting with hiv gp41
US7491489B2 (en) * 2004-11-22 2009-02-17 The University Of Hong Knog Synthetic peptide targeting critical sites on the SARS-associated coronavirus spike protein responsible for viral infection and method of use thereof
EP1868652A2 (en) * 2005-04-05 2007-12-26 Istituto di Richerche di Biologia Molecolare P. Angeletti S.p.A. Method for shielding functional sites or epitopes on proteins
CN101088557A (zh) 2006-06-12 2007-12-19 天津市扶素生物技术有限公司 用于预防或治疗hiv感染的药用组合物及其应用
EP2125876A1 (en) * 2007-03-12 2009-12-02 Thomas Jefferson University Tighter-binding c-peptide inhibitors of hiv-1 entry
WO2009030780A2 (en) * 2007-09-07 2009-03-12 Complix Nv Non-natural proteinaceous scaffold made of three non-covalently associated peptides
GB0720503D0 (en) * 2007-10-22 2007-11-28 Angeletti P Ist Richerche Bio New compound
GB2471692A (en) 2009-07-08 2011-01-12 Complix Nv HIV gp41-binding single-chain coiled-coil peptide comprising heptad repeats
US9050063B2 (en) * 2012-03-30 2015-06-09 Sandance Technology Llc Systems and methods for determining suitability of a mechanical implant for a medical procedure
CN106946994B (zh) * 2017-03-09 2019-11-26 中国医学科学院病原生物学研究所 一种抑制丙型肝炎病毒感染的蛋白及其应用
CN110551179B (zh) * 2018-05-31 2022-03-15 中国科学院微生物研究所 一种经修饰的抗hiv多肽及其制备方法和用途
US20250298022A1 (en) 2022-05-03 2025-09-25 Roche Diagnostics Operations, Inc. Hiv gp41 variants for immunodiagnostic assays

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444044A (en) 1992-03-26 1995-08-22 New York Blood Center Synthetic polypeptides as inhibitors of HIV-1
KR100358209B1 (ko) 1992-07-20 2003-01-24 듀크 유니버시티 Hiv복제를저해하는조성물
US5464933A (en) 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
US5780221A (en) * 1995-05-03 1998-07-14 Whitehead Institute For Biomedical Research Identification of enantiomeric ligands
AU723537B2 (en) 1995-06-07 2000-08-31 Trimeris Inc. The treatment of HIV and other viral infections using combinatorial therapy
JP3903503B2 (ja) 1996-11-18 2007-04-11 住友電気工業株式会社 可溶性ポリペプチド
WO1998032848A1 (en) * 1997-01-28 1998-07-30 The Regents Of The University Of California Peptide probes to coil proteins and methods for making the same
US6150088A (en) 1997-04-17 2000-11-21 Whitehead Institute For Biomedical Research Core structure of gp41 from the HIV envelope glycoprotein
US6818740B1 (en) * 1997-04-17 2004-11-16 Whitehead Institute For Biomedical Research Inhibitors of HIV membrane fusion
US6841657B2 (en) 1997-04-17 2005-01-11 Whitehead Institute For Biomedical Research Inhibitors of HIV membrane fusion
US6090911A (en) 1997-10-22 2000-07-18 University Of Massachusetts Reversible hydrogels
US6656906B1 (en) 1998-05-20 2003-12-02 Trimeris, Inc. Hybrid polypeptides with enhanced pharmacokinetic properties
EP1100818B1 (en) 1998-07-30 2013-01-02 Whitehead Institute For Biomedical Research Inhibitors of hiv membrane fusion
US7960504B2 (en) * 1998-07-30 2011-06-14 Whitehead Institute For Biomedical Research Inhibitors of HIV membrane fusion
US6747126B1 (en) * 1998-07-30 2004-06-08 Whitehead Institute For Biomedical Research Peptide inhibitors of HIV entry
CA2359892A1 (en) * 1999-01-08 2000-07-13 Panacos Pharmaceuticals, Inc. Methods of eliciting broadly neutralizing antibodies targeting hiv-1 gp41
CA2395291C (en) 1999-12-16 2012-09-11 Whitehead Institute For Biomedical Research Five-helix protein
US20030082525A1 (en) 1999-12-16 2003-05-01 Whitehead Institute For Biomedical Research Five-Helix protein
JP5180422B2 (ja) 2000-09-22 2013-04-10 ホワイトヘッド インスチチュート フォアー バイオメディカル リサーチ Hiv浸入のペプチドインヒビター

Similar Documents

Publication Publication Date Title
JP2003517006A5 (https=)
JP2004517472A5 (https=)
WO2002099027A3 (en) Solid cleaning composition including stabilized active oxygen component
DE60110438D1 (de) Zusammensetzungen enthaltend stilbenoide mit einer hypoglykämischen wirkung
DE60125825D1 (de) Parfümzusammensetzungen
BR0011267A (pt) Macroestruturas contendo metal de óxido inorgânico poroso, preparações dos mesmos e uso
JP2004523238A5 (https=)
AU2001263301A1 (en) Detergent containing alpha-sulfofatty acid esters and methods of making and using the same
CA2318868A1 (en) Chemical agent for improving the engineering properties of soil
JP2002544370A5 (https=)
WO2001074474A1 (fr) Procede de production d'agent de traitement de gaz de combustion
NO870559D0 (no) Bygningsplate, saerlig gipsplate.
Sanyal Negative environmental impacts of using conventional building materials and construction on urban housing interiors: a study.
ATE261413T1 (de) Eine basen- und säureresistente zusammensetzung
RU2002119230A (ru) Способ получения стирола
JP2002531058A5 (https=)
RU98121894A (ru) Негорючий теплоизоляционный материал
RU2000118975A (ru) Способ получения композиционного вяжущего
RU97115611A (ru) Бетонная смесь
RU2000118069A (ru) Добавка в бетонную смесь
RU98102987A (ru) Тампонажный материал
ATE193316T1 (de) Flüssiges scheuermittel
RU2001130830A (ru) Фунгицидный состав
ES2190703B1 (es) Composicion de lana mineral.
JP2004502668A5 (https=)